| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |